StopDown
New fund · 19 June 2026HealthQuadhealthcare venture capital firm

HealthQuad raises ₹550 crore in first close of Fund III to back Indian healthcare startups

By · Editor ·

Founded 2016
  • HealthQuad is a healthcare venture capital firm that invests in early-growth companies across healthtech, medtech, biopharma technology, and new healthcare…
  • HealthQuad Fund III has raised ₹550 crore in its first close, with a target of ₹1,700 crore and a greenshoe option that could increase the total to ₹2,500 crore
  • The fund focuses on India, with a discretionary share for Southeast Asia, and has already invested in LifeSigns, an AI-powered remote patient monitoring…

What happened

  • HealthQuad, a healthcare venture capital firm backed by Quadria Group, has raised ₹550 crore in the first close of its third fund, HealthQuad Fund III.
  • The fund targets ₹1,700 crore with a greenshoe option that could increase the total to ₹2,500 crore.
  • The commitments have come from existing investors in HealthQuad’s earlier funds, as well as new limited partners, including local and global funds of funds, institutions, and family offices.
  • The fund has already made its first investment in LifeSigns, an AI-powered remote patient monitoring platform.
  • HealthQuad Fund III is managed by HealthQuad Advisors Private Limited, a vehicle 100% owned by Quadria Group.
  • Following the mutual separation between KOIS and Quadria Group in 2025, Quadria Group retained a majority of the team managing HealthQuad’s prior funds and expanded its leadership with the addition of Rahul Agarwal and Namit Chugh.
  • HealthQuad was founded in 2016 as Quadria’s early-growth vehicle for technology-led healthcare companies.
  • Its portfolio includes Qure.ai, Wysa, Redcliffe Labs, GoApptiv, CureSkin, Strand Life Sciences, THB, ekincare, and Medikabazaar.

Why it matters

  • HealthQuad Fund III targets 13-15 healthtech startups across AI-driven healthcare, digital therapeutics, ambulatory care, enterprise SaaS, and point-of-care devices.
  • The fund focuses on India, with a discretionary share for other markets in Southeast Asia.
  • HealthQuad’s earlier two funds had backed 18 healthtech startups, including GoApptiv, Qure.ai, Redcliffe Labs, CureSkin, Strand Life Sciences, Medikabazaar, THB, Wysa, and ekincare.
  • The Indian healthtech segment has a track record of strong innovations but has lacked institutional backing.

The business

  • HealthQuad is a healthcare venture capital firm that invests in early-growth companies across healthtech, medtech, biopharma technology, and new healthcare delivery models.
  • The firm focuses on India, with a discretionary share for Southeast Asia.
  • HealthQuad Fund III targets 13-15 healthtech startups across AI-driven healthcare, digital therapeutics, ambulatory care, enterprise SaaS, and point-of-care devices.
  • The fund has already invested in LifeSigns, an AI-powered remote patient monitoring platform.
  • HealthQuad was founded in 2016 as Quadria’s early-growth vehicle for technology-led healthcare companies.
  • Its portfolio includes Qure.ai, Wysa, Redcliffe Labs, GoApptiv, CureSkin, Strand Life Sciences, THB, ekincare, and Medikabazaar.

The founders

Amit Varma

key person
  • Amit Varma is a key person at HealthQuad Advisors Private Limited, a vehicle 100% owned by Quadria Group.

Abrar Mir

key person
  • Abrar Mir is a key person at HealthQuad Advisors Private Limited, a vehicle 100% owned by Quadria Group.

Sunil Thakur

Co-founder and IC Member
  • Sunil Thakur is a co-founder and IC Member of HealthQuad and a Partner at Quadria Capital.

Rahul Agarwal

Partner and IC Member
  • Rahul Agarwal is a Partner and IC Member of HealthQuad and was added to the leadership team following the separation between KOIS and Quadria Group in 2025.

Namit Chugh

added to leadership
  • Namit Chugh was added to the leadership team following the separation between KOIS and Quadria Group in 2025.

Who put in money

  • existing investors existing — existing limited partners in HealthQuad’s earlier funds
  • new limited partners participated — local and global funds of funds, institutions, and family offices

In numbers

₹1,700 croreFund III target · 2026
₹2,500 croreFund III greenshoe option · 2026
18 healthtech startupsHealthQuad’s portfolio · 2026
LifeSignsHealthQuad’s first investment in Fund III · 2026

What happens next

  • HealthQuad Fund III will continue to support healthcare startups focused on improving access, affordability, and quality of care through technology, business model innovation, and product development.

Earlier rounds

  • 2026-06-19 · first close · ₹550 crore · led by Quadria Group

Up against

HealthKios

In their words

“Healthcare is undergoing one of the most significant transformations in recent times. We believe the next decade will be defined by companies that leverage emerging technologies and AI, and innovative models to make healthcare more accessible, affordable and outcome driven.”Rahul Agarwal, Partner and IC Member, HealthQuad
“HealthQuad was created with a simple belief that healthcare requires specialist investors who understand the sector deeply and can support founders through long, arduous growth journeys.”Sunil Thakur, Co-founder and IC Member, HealthQuad, and Partner, Quadria Capital

Words to know

greenshoe option
an option that allows the fund to raise additional capital beyond the initial target, if needed.
limited partners (LPs)
investors who provide capital to a fund but have limited liability and do not participate in its management.
venture capital (VC)
a type of financing provided to early-stage companies with high growth potential.
healthtech
the application of technology to improve healthcare delivery, including digital therapeutics, AI, and remote patient monitoring.

The numbers around it

Healthcare & Life Sciences in June 2026: 11 rounds with a disclosed amount, $118 million in all; the biggest was Vetic ($40 Mn). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.
  • Greenshoe option: A greenshoe option, called a green shoe option in Indian rules, is a facility in an IPO that lets the company allot extra shares beyond the planned offer, so a bank can buy them back in the market and steady the price after listing. In India it sits in the SEBI ICDR Regulations and is allowed up to 15% of the issue, though it is used rarely.
  • First close: A first close is the point at which a venture capital or private equity fund accepts its first batch of investor commitments and can start work. The final close is the last date on which new investors may join, which fixes the fund's size.

All startup news on 19 June 2026 →

Is this HealthQuad? Get your “Featured on StopDown” badge →